Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience

Author:

Garrafa Emirena12ORCID,Brugnoni Duilio2ORCID,Barbaro Mosè2,Andreoli Laura31ORCID,Focà Emanuele14ORCID,Salvetti Massimo15,Castelli Francesco14ORCID,Franceschini Franco31ORCID,Piva Simone67ORCID,Muiesan Maria Lorenza15,Latronico Nicola67ORCID,Levaggi Rosella8ORCID

Affiliation:

1. Department of Clinical & Experimental Sciences, University of Brescia, Brescia, Italy

2. Department of Laboratory Diagnostics, ASST Spedali Civili, Brescia, Italy

3. Unit of Rheumatology & Clinical Immunology, ASST Spedali Civili, Brescia, Italy

4. 2nd Medicine Unit, ASST Spedali Civili, Brescia, Italy

5. University Division of Infectious & Tropical Diseases, ASST Spedali Civili, Brescia, Italy

6. Department of Anesthesia, Critical Care and Emergency, Spedali Civili University Hospital, Brescia, Italy

7. Department of Medical & Surgical Specialties, Radiological Sciences & Public Health, University of Brescia, Brescia, Italy

8. Department of Economics & Management, University of Brescia, Brescia, Italy

Abstract

Coronavirus disease 2019 emergency has created an enormous stress on providers that have been transformed into coronavirus disease hospitals. This article presents the experience of the clinical laboratory of Spedali Civili in Brescia (a teaching hospital in Lombardy with over 1500 beds) in managing the crisis, and to offer practical considerations for laboratory testing for this cohort of patients. Our contribution is threefold: by comparing the demand for tests in two representative period before and within the crisis, we show the change in compositions of the analytes that other labs may expect; we present the new panels of tests that hospital staff can order with different advantage for wards and laboratory; and we show how to reorganize staff on the basis of changes mentioned above.

Publisher

Future Science Ltd

Subject

Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3